Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Artiva to quit autoimmune cell therapy work, cut staff after patient deaths

The disclosure makes Artiva the third company to recently report fatal events in an autoimmune cell therapy trial, following announcements from Novartis and Bristol Myers Squibb.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

More from Tuesday 27 October →